Eli Lilly (LLY) FCF Margin (2009 - 2026)
Eli Lilly (LLY) recorded FCF Margin of 33.69% in Q3 2026, down 4.65 percentage points from 38.34% a year earlier and down 0.08 percentage points from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) FCF Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Eli Lilly's FCF Margin came in at 22.74% as of Sep 30, 2026, up 7.14 percentage points year-over-year; for FY2025, it came in at 13.77%, up 5.42 percentage points from FY2024.
- Annual FCF Margin has a five-year change of -7.07 percentage points (FY2020 to FY2025).
- Across earlier years, FCF Margin came in at 8.35% in FY2024 (+6.03 pp), 2.32% in FY2023 (-17.76 pp), 20.08% in FY2022 (-1.30 pp) and 21.39% in FY2021 (+0.56 pp).
- Quarterly FCF Margin has ranged from -14.79% in Q4 2023 to 38.34% in Q3 2025 over the past five years.
- On a year-over-year basis, FCF Margin rose in five of the last eight quarters, with an average year-over-year change of +9.51 percentage points.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 24.83 percentage points in Q2 2026, against a drop of 30.70 percentage points in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 33.76% (Q2 2026), 15.19% (Q1 2026) and 3.51% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 28.96% |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 15.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 33.69% |
| Jun 30, 2026 | 33.76% |
| Mar 31, 2026 | 15.19% |
| Dec 31, 2025 | 3.51% |
| Sep 30, 2025 | 38.34% |
| Jun 30, 2025 | 8.93% |
| Mar 31, 2025 | 1.23% |
| Dec 31, 2024 | 7.22% |
| Sep 30, 2024 | 20.64% |
| Jun 30, 2024 | 2.14% |
| Mar 31, 2024 | 2.05% |
| Dec 31, 2023 | -14.79% |
| Sep 30, 2023 | 12.84% |
| Jun 30, 2023 | -1.28% |
| Mar 31, 2023 | 15.26% |
| Dec 31, 2022 | 15.91% |
| Sep 30, 2022 | 23.04% |
| Jun 30, 2022 | 12.52% |
| Mar 31, 2022 | 27.63% |
| Dec 31, 2021 | 24.63% |
API Access
Eli Lilly FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();